Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
J., Bozinovski, S., Anderson, G
Every step of our program is built on a foundation of medical expertise and ethical care
Semaglutide (the active ingredient in Ozempic and Wegovy) operates through GLP-1 receptor activation alone
What It Targets Our AOD-9604 peptides are designed to target: Stubborn body fat and slow fat loss in clients already working on nutrition, steps, and strength training. Mild to moderate central adiposity where clients want incremental support rather than a primary weight-loss medication. Clients who cannot or do not wish to use GLP1s but still want to explore peptide-based metabolic support under a transparent riskbenefit discussion. Aesthetic-focused body recomposition journeys where even small improvements in fatmuscle balance can enhance contouring results
It works by mimicking the effects of two hormones involved in blood sugar regulation and appetite control
US$ 26.65
US$ 20.88
US$ 22.59
US$ 20.23
